Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 611 articles:
HTML format



Single Articles


    November 2021
  1. LEITE-GOMES E, Dias AM, Azevedo CM, Santos-Pereira B, et al
    Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446097. doi: 10.1093.
    PubMed     Abstract available


  2. SUN Y, Geng J, Chen X, Chen H, et al
    Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445975. doi: 10.1093.
    PubMed     Abstract available


  3. CERNA K, Duricova D, Lukas M, Machkova N, et al
    Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445976. doi: 10.1093.
    PubMed     Abstract available


  4. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446094. doi: 10.1093.
    PubMed     Abstract available


  5. BIRDA CL, Agarwal A, Goyal A
    A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438178. doi: 10.1093.
    PubMed    


  6. DESALERMOS A, Pimienta M, Kalligeros M, Shehadeh F, et al
    Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438176. doi: 10.1093.
    PubMed     Abstract available


  7. KJELDSEN S, Nielsen J, Mertz Norgard B, Kjeldsen J, et al
    Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438420. doi: 10.1093.
    PubMed     Abstract available


  8. WESTBERG K, Olen O, Soderling J, Bengtsson J, et al
    Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 18. pii: 6430979. doi: 10.1093.
    PubMed     Abstract available


  9. SACHAN A, Singh AK
    Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.
    Inflamm Bowel Dis. 2021 Nov 15. pii: 6428578. doi: 10.1093.
    PubMed    


  10. PAPALIA I, Tjandra D, Quah S, Tan C, et al
    Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  11. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426108. doi: 10.1093.
    PubMed    


  12. HOKAMA A, Fujita J
    Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?"
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426022. doi: 10.1093.
    PubMed    


  13. LUTZ MK, Matthews LA, Tuan WJ, Caldera F, et al
    Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425060. doi: 10.1093.
    PubMed    


  14. JAGT JZ, Struys EA, Ayada I, Bakkali A, et al
    Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425057. doi: 10.1093.
    PubMed     Abstract available


  15. JENA A, Singh AK, Siddharda BV, Panda P, et al
    Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 9. pii: 6425058. doi: 10.1093.
    PubMed    


  16. ZHANG S, Chen F, Wu J, Liu C, et al
    Regional Gray Matter Volume Changes in Brains of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 3. pii: 6420319. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  17. TRIPATHI K, Godoy Brewer G, Thu Nguyen M, Singh Y, et al
    COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412576. doi: 10.1093.
    PubMed     Abstract available


  18. DAI C, Huang YH, Jiang M
    Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412248. doi: 10.1093.
    PubMed    


  19. KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
    The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021;27:1731-1739.
    PubMed     Abstract available


  20. SPENCER EA, Klang E, Dolinger M, Pittman N, et al
    Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:1862-1864.
    PubMed    


  21. CRISPINO F, Brinch D, Carrozza L, Cappello M, et al
    Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Inflamm Bowel Dis. 2021;27:e134-e135.
    PubMed    


  22. DALAL RS, Allegretti JR
    Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:1873-1875.
    PubMed    


  23. CALDERA F, Balzora S, Hayney MS, Farraye FA, et al
    Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1703-1705.
    PubMed     Abstract available


  24. REENAERS C, de Roover A, Kohnen L, Nachury M, et al
    Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
    PubMed     Abstract available


  25. ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
    IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
    PubMed     Abstract available


  26. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed     Abstract available


  27. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.
    PubMed    


  28. RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
    Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  29. LEE KE, Lim F, Colombel JF, Hur C, et al
    Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378418. doi: 10.1093.
    PubMed     Abstract available


  30. GU X, Ke X, Shen M, Zhang M, et al
    Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378417. doi: 10.1093.
    PubMed    


  31. MICHEL HK, Boyle B, David J, Donegan A, et al
    The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.
    Inflamm Bowel Dis. 2021 Sep 25. pii: 6375326. doi: 10.1093.
    PubMed     Abstract available


  32. BOOTH A, Ford W, Brennan E, Magwood G, et al
    Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 23. pii: 6374390. doi: 10.1093.
    PubMed     Abstract available


  33. MACISAAC MB, Julsgaard M, Flanagan E, Rowe S, et al
    Anti-TNFalpha Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
    Inflamm Bowel Dis. 2021 Sep 18. pii: 6372251. doi: 10.1093.
    PubMed    


  34. LAWTON RC
    "The Tough Get Going": Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 17. pii: 6371841. doi: 10.1093.
    PubMed    


  35. DAILEY J, Kozhaya L, Dogan M, Hopkins D, et al
    Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 16. pii: 6371006. doi: 10.1093.
    PubMed     Abstract available


  36. OUAHED J
    Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370827. doi: 10.1093.
    PubMed     Abstract available


  37. BADER-MEUNIER B, Martins AL, Charbit-Henrion F, Meinzer U, et al
    Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370829. doi: 10.1093.
    PubMed     Abstract available


  38. VAHIDNEZHAD H, Youssefian L, Anbardar MH, Zeinali S, et al
    Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the alpha6 Integrin Gene (ITGA6).
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370826. doi: 10.1093.
    PubMed    


  39. MISHRA S, Kumar Singh A, Kopp C, Jena A, et al
    Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370835. doi: 10.1093.
    PubMed    


  40. DE VOOGD F, Joshi H, Van Wassenaer E, Bots S, et al
    Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370832. doi: 10.1093.
    PubMed     Abstract available


  41. WU N, Li H, Zhang J, Huang W, et al
    Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?
    Inflamm Bowel Dis. 2021 Sep 4. pii: 6364140. doi: 10.1093.
    PubMed    


  42. HERMAN SM, Zaborniak K, Bernstein CN
    Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362805. doi: 10.1093.
    PubMed     Abstract available


  43. BARNES EL, Nowell WB, Venkatachalam S, Dobes A, et al
    Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362806. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  44. PHILIPPOU A, Sehgal P, Ungaro RC, Wang K, et al
    High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358608. doi: 10.1093.
    PubMed     Abstract available


  45. XERFAN EMS, Andersen ML, Tomimori J, Tufik S, et al
    Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358561. doi: 10.1093.
    PubMed    


  46. RAFFALS LE, Saha S, Bewtra M, Norris C, et al
    The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358125. doi: 10.1093.
    PubMed     Abstract available


  47. MATSUNE Y, Yaguchi K, Saito S, Sakakibara H, et al
    Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum.
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358126. doi: 10.1093.
    PubMed    


  48. HASSAN-ZAHRAEE M, Ye Z, Xi L, Baniecki ML, et al
    Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357022. doi: 10.1093.
    PubMed     Abstract available


  49. MALHI G, Tandon P, Perlmutter JW, Nguyen G, et al
    Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357024. doi: 10.1093.
    PubMed     Abstract available


  50. XU Y, Tian Y, Li F, Wang Y, et al
    Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357021. doi: 10.1093.
    PubMed     Abstract available


  51. SABERZADEH-ARDESTANI B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, et al
    Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Inflamm Bowel Dis. 2021 Aug 21. pii: 6356100. doi: 10.1093.
    PubMed     Abstract available


  52. YANG Q, Chen L, Feng L, Liu C, et al
    Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 16. pii: 6352953. doi: 10.1093.
    PubMed     Abstract available


  53. DEL SORDO R, Lupinacci G, Tanzi G, Bassotti G, et al
    Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
    Inflamm Bowel Dis. 2021 Aug 10. pii: 6347487. doi: 10.1093.
    PubMed    


    July 2021
  54. UNGARO RC, Agrawal M, Brenner EJ, Zhang X, et al
    New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329562. doi: 10.1093.
    PubMed    


  55. FALSEY A, Jo D, Sirak H, Moya D, et al
    Corticosteroids Can Be Used to Decrease Antidrug Antibodies in Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329558. doi: 10.1093.
    PubMed    


  56. AXELRAD JE, Faye A, Slaughter JC, Harpaz N, et al
    Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329560. doi: 10.1093.
    PubMed     Abstract available


  57. MARKOVIC S, Ivanovski TK, Zogovic B, Kalaba A, et al
    The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.
    Inflamm Bowel Dis. 2021;27:e90.
    PubMed    


  58. WINTER MW, Levy LC
    Maybe Age Isn't Just a Number: Elderly-onset IBD Is a Demographic Deserving of Specific Considerations.
    Inflamm Bowel Dis. 2021;27:1363-1364.
    PubMed    


  59. CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
    Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
    PubMed    


  60. SYAL G, Serrano M, Jain A, Cohen BL, et al
    Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
    PubMed     Abstract available


  61. DAI C, Jiang M, Huang YH
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
    PubMed    


  62. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
    PubMed     Abstract available


  63. SHIBUYA T, Nomura O, Nagahara A
    Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
    Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
    PubMed    


  64. OJO BA, VanDussen KL, Rosen MJ
    The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
    PubMed     Abstract available


  65. WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
    Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
    PubMed     Abstract available


  66. KHAN N, Pernes T, Weiss A, Trivedi C, et al
    Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
    PubMed     Abstract available


  67. TSE CS, Singh S, Sandborn WJ
    A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  68. WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
    SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
    PubMed    


  69. CHOSHEN S, Turner D, Pratt LT, Precel R, et al
    Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
    PubMed     Abstract available


  70. TAFT TH, Quinton S, Jedel S, Simons M, et al
    Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
    PubMed     Abstract available


  71. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
    PubMed     Abstract available


  72. MUTLU EA
    IBD Development After Diverticulitis May Hold Clues to IBD Pathogenesis.
    Inflamm Bowel Dis. 2021;27:1172-1173.
    PubMed    


  73. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:e79-e80.
    PubMed    


  74. QIN X
    High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
    PubMed    


  75. GALIPEAU HJ, Caminero A, Verdu EF
    Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
    PubMed    


  76. LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
    Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
    PubMed    


  77. GONG L, Xiao J, Yi J, Xiao J, et al
    Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
    PubMed     Abstract available


  78. VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
    Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
    PubMed     Abstract available


  79. DAVID JG, Chute D, Reed B, Saeed S, et al
    Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
    PubMed    


  80. JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
    Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
    PubMed     Abstract available


  81. DANESE S, Peyrin-Biroulet L
    Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
    PubMed     Abstract available


  82. MIKAIL M, Wilson A
    Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
    PubMed    


    May 2021
  83. LUI J, Ramos GP, Codipilly DC, Katzka D, et al
    The Use of Biologics for the Treatment of Esophageal Crohn Disease.
    Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
    PubMed    


  84. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed    


  85. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed     Abstract available


  86. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed    


  87. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed     Abstract available


  88. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed     Abstract available


  89. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed     Abstract available


  90. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed     Abstract available


  91. IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
    Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
    PubMed     Abstract available


  92. SACHAN A, Srivastava S, Shah J, Singh AK, et al
    Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
    Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
    PubMed    


  93. HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
    Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
    PubMed    


  94. HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
    Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
    PubMed     Abstract available


  95. VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
    Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
    PubMed     Abstract available


  96. MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
    The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
    PubMed     Abstract available


  97. CHEAH M, Wilson A, Solh Z, Khanna R, et al
    IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
    PubMed    


  98. VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
    Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
    PubMed    


  99. DOS SANTOS CHM, Koga GA
    Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
    Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
    PubMed    


  100. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
    PubMed    


  101. SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
    PubMed    


  102. DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
    Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
    PubMed     Abstract available


  103. HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
    Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
    PubMed    


  104. FASOULAS K, Stergiou E, Soufleris K
    Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
    PubMed    


  105. SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
    PubMed     Abstract available



  106. Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
    PubMed    



  107. Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
    PubMed    


  108. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed     Abstract available


  109. GRAZIANO F, Buse M, Cassata N, Citrano M, et al
    Cerebral Venous Thrombosis in a Child With Very-Early-Onset IBD.
    Inflamm Bowel Dis. 2021;27:e71-e73.
    PubMed    


  110. SRINIVASAN A, van Langenberg D, De Cruz P
    Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e69.
    PubMed    


  111. AHMED W, Lukin DJ
    Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
    Inflamm Bowel Dis. 2021;27:787-790.
    PubMed    


  112. TAXONERA C, Olivares D, Alba C
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
    PubMed    


  113. JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
    Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
    PubMed    


  114. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
    PubMed     Abstract available


  115. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
    PubMed    


  116. CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
    Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
    PubMed     Abstract available


  117. JENA A, Mishra S, Sachan A, Singh H, et al
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
    PubMed    


  118. MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
    Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
    PubMed     Abstract available


  119. ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
    Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
    Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  120. XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
    COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
    PubMed    


  121. HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
    Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
    PubMed     Abstract available


  122. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
    Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
    PubMed    



  123. Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
    PubMed    


  124. ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
    Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Inflamm Bowel Dis. 2021;27:e66.
    PubMed    


  125. GOREN G, Schwartz D, Friger M, Banai H, et al
    Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
    PubMed     Abstract available


  126. ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
    Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
    PubMed     Abstract available


  127. SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
    Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
    Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  128. HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
    Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
    Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
    PubMed     Abstract available


  129. FANG J, Wang H, Xue Z, Cheng Y, et al
    PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
    PubMed     Abstract available


  130. SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
    Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
    PubMed     Abstract available


  131. KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
    Trajectories of Fatigue in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
    PubMed     Abstract available


  132. STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
    The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
    PubMed     Abstract available


  133. ZHANG T, Xu Y, Yao Y, Jin L, et al
    Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
    PubMed     Abstract available


  134. SANDS BE, Long MD, Reinisch W, Panes J, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
    PubMed     Abstract available


  135. GARRIDO I, Lopes S, Macedo G
    Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
    PubMed     Abstract available


  136. KHORSHID M, AbdAllah M
    Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Inflamm Bowel Dis. 2021;27:e39.
    PubMed    


  137. WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
    Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:590-592.
    PubMed    


  138. AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
    Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Inflamm Bowel Dis. 2021;27:585-589.
    PubMed    


  139. SANTANA GO, de Santana AC, Pfeilsticker VB
    Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
    Inflamm Bowel Dis. 2021;27:e42.
    PubMed    


  140. PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
    Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
    PubMed     Abstract available


  141. BHAT S, Caldera F, Farraye FA
    Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
    PubMed    


  142. ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
    Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
    PubMed     Abstract available


  143. XIANG BJ, Huang YH, Dai C
    A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
    PubMed    


  144. SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
    The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
    PubMed     Abstract available


  145. ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
    Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
    PubMed     Abstract available


  146. TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
    Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
    PubMed    


    February 2021
  147. VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
    PubMed     Abstract available


  148. NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
    Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
    PubMed    


  149. IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
    SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
    PubMed    


  150. BORGHINI R, Vescovo M, Giordano C, Donato G, et al
    Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
    PubMed    


  151. MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
    Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
    PubMed     Abstract available


  152. CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
    Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
    PubMed     Abstract available


  153. MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
    PubMed     Abstract available


  154. TAXONERA C, Olivares D, Alba C
    Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
    PubMed     Abstract available


  155. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
    Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
    PubMed     Abstract available


  156. DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
    PubMed     Abstract available


  157. DALAL RS, Allegretti JR
    Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
    PubMed    


  158. JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
    Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
    Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
    PubMed    


  159. MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
    Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
    PubMed     Abstract available


  160. BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
    Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
    Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
    PubMed     Abstract available


  161. DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
    Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
    PubMed     Abstract available


  162. BALDAN-MARTIN M, Chaparro M, Gisbert JP
    Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
    PubMed     Abstract available


  163. GARG R, Mohammed A, Singh A, Regueiro M, et al
    Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  164. RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
    International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
    PubMed     Abstract available


  165. ROBERTSON AR, Arnott ID
    How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
    PubMed    



  166. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
    PubMed    


  167. SHAH J, Shah A, Hassman L, Gutierrez A, et al
    Ocular Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
    PubMed     Abstract available


  168. CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
    Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
    PubMed    


  169. DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
    Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
    PubMed    


  170. SORRENTINO D, Gray JM
    Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
    PubMed     Abstract available


  171. SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
    Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
    PubMed     Abstract available


  172. SEDANO R, Jairath V
    Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
    PubMed    


  173. SEDANO R, Jairath V
    High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
    PubMed    


  174. BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
    Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:155-161.
    PubMed     Abstract available


  175. HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
    Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Inflamm Bowel Dis. 2021;27:291-294.
    PubMed    


  176. BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
    Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
    PubMed     Abstract available


  177. DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
    Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
    PubMed    


  178. TA AD, Ollberding NJ, Karns R, Haberman Y, et al
    Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
    PubMed     Abstract available


  179. ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
    The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
    PubMed    


  180. CHANDE N, Singh S, Narula N, Gordon M, et al
    Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
    PubMed    


  181. WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
    Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
    PubMed     Abstract available


  182. LI N, Zhan S, Tian Z, Liu C, et al
    Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
    PubMed     Abstract available


  183. REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
    Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
    PubMed     Abstract available


  184. FOULON A, Pichois R, Sabbagh C, Fumery M, et al
    Bowel Endometriosis Mimicking Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
    PubMed    


  185. PUGLIESE D, Schepis T, Bove V, Privitera G, et al
    Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
    PubMed    


  186. KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
    Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
    PubMed     Abstract available


  187. HONG S, Zaki TA, Main M, Hine AM, et al
    Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
    PubMed     Abstract available


  188. SCHARRER S, Primas C, Eichinger S, Tonko S, et al
    Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
    PubMed     Abstract available


  189. BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
    Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
    PubMed    


  190. JEON Y, Limketkai BN
    Implications of Dietary Impact on Hepatic Steatosis and IBD.
    Inflamm Bowel Dis. 2021;27:10-11.
    PubMed    


  191. PENRICE DD, Kamboj AK, Simonetto DA
    Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
    Inflamm Bowel Dis. 2021;27:e7-e8.
    PubMed    


  192. REINISCH W, Gecse K, Halfvarson J, Irving PM, et al
    Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:106-122.
    PubMed     Abstract available


  193. RIPOLLES T, Poza J, Suarez Ferrer C, Martinez-Perez MJ, et al
    Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study.
    Inflamm Bowel Dis. 2021;27:145-154.
    PubMed     Abstract available


  194. OLAISEN M, Flatberg A, Granlund AVB, Royset ES, et al
    Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:12-24.
    PubMed     Abstract available


  195. CHICCO F, Magri S, Cingolani A, Paduano D, et al
    Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Inflamm Bowel Dis. 2021;27:1-9.
    PubMed     Abstract available


  196. CALDERA F, Ley D, Hayney MS, Farraye FA, et al
    Optimizing Immunization Strategies in Patients with IBD.
    Inflamm Bowel Dis. 2021;27:123-133.
    PubMed     Abstract available


  197. ARVANITIS M, Hart LC, DeWalt DA, Diaz-Gonzalez de Ferris ME, et al
    Transition Readiness Not Associated With Measures of Health in Youth With IBD.
    Inflamm Bowel Dis. 2021;27:49-57.
    PubMed     Abstract available


  198. SZIGETHY E, Murphy SM, Ehrlich OG, Engel-Nitz NM, et al
    Mental Health Costs of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:40-48.
    PubMed     Abstract available


  199. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2021;27:34-39.
    PubMed     Abstract available


  200. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort.
    Inflamm Bowel Dis. 2021;27:65-73.
    PubMed     Abstract available


    December 2020
  201. HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
    Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
    PubMed     Abstract available


  202. HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
    Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
    Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
    PubMed    


  203. BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
    Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
    PubMed     Abstract available


  204. QIN X
    More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
    PubMed    


  205. CURTIS JR, Regueiro M, Yun H, Su C, et al
    Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
    Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
    PubMed     Abstract available


  206. DWADASI S, Zafer M, Goens D, Paknikar R, et al
    Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
    PubMed     Abstract available


  207. PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
    Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
    PubMed     Abstract available


  208. MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
    The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
    PubMed     Abstract available


  209. LEE C, Hong SN, Kim ER, Chang DK, et al
    Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
    PubMed     Abstract available


  210. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
    PubMed     Abstract available


  211. LEE SH, Walshe M, Oh EH, Hwang SW, et al
    Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
    Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  212. BATTAT R, Lukin D, Scherl EJ, Pola S, et al
    Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
    PubMed     Abstract available


  213. BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
    Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
    PubMed     Abstract available


  214. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
    PubMed     Abstract available


  215. DIMOPOULOS C, Al-Bawardy B
    SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e153-e154.
    PubMed    


  216. UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
    Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
    PubMed     Abstract available


  217. BROMS G, Friedman S, Kim SC, Wood ME, et al
    The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
    PubMed     Abstract available


  218. GEEM D, Kugathasan S
    It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
    PubMed    


  219. SEDANO R, Jairath V
    Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
    PubMed    


  220. ATTAUABI M, Burisch J, Seidelin JB
    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
    PubMed    


  221. GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
    Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
    Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
    PubMed     Abstract available


  222. BRETON J, Witmer CM, Zhang Y, Downing M, et al
    Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
    PubMed     Abstract available


  223. SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
    Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
    PubMed     Abstract available


  224. RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
    The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
    PubMed     Abstract available


  225. SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
    Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
    PubMed     Abstract available


  226. CORDES F, Lenker E, Weinhage T, Spille LJ, et al
    Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
    PubMed     Abstract available


  227. SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
    PubMed    


  228. HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
    Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
    PubMed     Abstract available


  229. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
    PubMed     Abstract available


  230. BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
    Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
    PubMed     Abstract available


  231. BLOOMFELD RS, Bickston SJ
    Financial Toxicity in People With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  232. DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
    Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
    PubMed     Abstract available


  233. RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
    The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
    PubMed     Abstract available


  234. BEHZAD C, Taheri H, Kashifard M
    Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e140.
    PubMed    


  235. HORRIGAN JM, Siegel CA, Tadros M
    Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e137.
    PubMed    


  236. ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
    Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:1771-1778.
    PubMed    


  237. MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
    Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
    PubMed     Abstract available


  238. FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
    Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
    PubMed     Abstract available


  239. RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
    Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
    Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
    PubMed     Abstract available


  240. KE J, He R, Hou X
    Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
    PubMed    


  241. ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
    Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
    PubMed     Abstract available


  242. VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
    Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
    PubMed     Abstract available


  243. DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
    Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
    PubMed    


  244. CHEN G, Lissoos T, Dieyi C, Null KD, et al
    Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
    PubMed     Abstract available


  245. DOS SANTOS CHM, Koga GA
    The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
    PubMed    


  246. TRINDADE IA, Ferreira NB
    COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
    PubMed     Abstract available


  247. MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
    Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
    PubMed    


  248. FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
    Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
    Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
    PubMed    


  249. FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
    Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  250. YU Q
    Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
    PubMed     Abstract available


  251. PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
    Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
    PubMed     Abstract available


  252. KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
    Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
    PubMed     Abstract available


  253. SINH P, Cross R
    Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
    PubMed     Abstract available


  254. SANDBORN WJ, Feagan BG, Danese S, O'Brien CD, et al
    Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2020 Sep 23. pii: 5910238. doi: 10.1093.
    PubMed     Abstract available


  255. VIGANO C, Massironi S, Pirola L, Cristoferi L, et al
    COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
    Inflamm Bowel Dis. 2020 Sep 19. pii: 5908896. doi: 10.1093.
    PubMed    


  256. HONAP S, Cookson H, Sharma E, Samaan MA, et al
    Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.
    Inflamm Bowel Dis. 2020 Sep 18. pii: 5908061. doi: 10.1093.
    PubMed    


  257. CASTELLINI G, Savarese M, Leone S, Previtali E, et al
    Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care.
    Inflamm Bowel Dis. 2020;26:e130-e131.
    PubMed    


  258. OCCHIPINTI V, Sociale OR, Pastorelli L
    Response to "Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care".
    Inflamm Bowel Dis. 2020;26:e123.
    PubMed    


  259. RIMONDI A, Tontini GE, Mazza S, Caprioli F, et al
    Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.
    Inflamm Bowel Dis. 2020;26:e128-e129.
    PubMed    


  260. BURGUENO JF, Abreu MT
    Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020;26:e127.
    PubMed    


  261. AZIZ M, Fatima R, Haghbin H, Lee-Smith W, et al
    The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
    Inflamm Bowel Dis. 2020;26:e132-e133.
    PubMed    


  262. CLOUGH JN, Hill KL, Duff A, Sharma E, et al
    Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
    Inflamm Bowel Dis. 2020;26:e125-e126.
    PubMed    


  263. NAVANEETHAN U, LehnerNoguera V
    Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Inflamm Bowel Dis. 2020;26:e124.
    PubMed    


  264. KORNBLUTH A, Kissous-Hunt M, George J, Legnani P, et al
    Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900880. doi: 10.1093.
    PubMed    


  265. KOUTROUMPAKIS F, Phillips AE, Yadav D, Machicado JD, et al
    Serum IgG4 Subclass Deficiency Defines a Distinct, Commonly Encountered, Severe Inflammatory Bowel Disease Subtype.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900865. doi: 10.1093.
    PubMed     Abstract available


  266. SITKIN S, Vakhitov T, Kononova S, Skalinskaya M, et al
    Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900883. doi: 10.1093.
    PubMed    


  267. SANDS BE, Colombel JF, Ha C, Farnier M, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900074. doi: 10.1093.
    PubMed     Abstract available


  268. SYED S, Stidham RW
    Potential for Standardization and Automation for Pathology and Endoscopy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900066. doi: 10.1093.
    PubMed     Abstract available


  269. BEZZIO C, Pellegrini L, Manes G, Arena I, et al
    Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900070. doi: 10.1093.
    PubMed    


    August 2020
  270. ALBSHESH A, Ungar B, Ben-Horin S, Eliakim R, et al
    Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 29. pii: 5898844. doi: 10.1093.
    PubMed     Abstract available


  271. GUERRA I, Algaba A, Jimenez L, Mar Aller M, et al
    Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Inflamm Bowel Dis. 2020 Aug 24. pii: 5896213. doi: 10.1093.
    PubMed     Abstract available


  272. COHEN BL, Gallinger ZR, Ha C, Holubar SD, et al
    Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
    Inflamm Bowel Dis. 2020;26:1291-1305.
    PubMed     Abstract available


  273. ZHANG Q, Chen D, Yang Y
    Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2020;26:e101.
    PubMed    


  274. HU AB, Burke KE, Kochar B, Ananthakrishnan AN, et al
    Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894187. doi: 10.1093.
    PubMed     Abstract available


  275. PALACIOS ARGUETA P, Salazar M, Attar B, Simons-Linares R, et al
    90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894152. doi: 10.1093.
    PubMed     Abstract available


  276. MAVRAGANI CP, Nezos A, Dovrolis N, Andreou NP, et al
    Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894175. doi: 10.1093.
    PubMed     Abstract available


  277. TOWNSEND T, Fiske J, Collins P, Bond A, et al
    Ambulatory Management of Acute Severe Ulcerative Colitis: A Pandemic-driven Initiative.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894170. doi: 10.1093.
    PubMed    


  278. SUGIMOTO K, Fujita S, Miyazu T, Ishida N, et al
    Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894173. doi: 10.1093.
    PubMed    


  279. JOSE DA SILVA R, da Rocha Ribeiro TC, Chebli LA, Chebli JMF, et al
    An Unexpected Cause of Headache and Splenic Lesions During Anti-TNF Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894171. doi: 10.1093.
    PubMed    


  280. DUBINSKY MC, DiBonaventura M, Fan H, Bushmakin AG, et al
    Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892619. doi: 10.1093.
    PubMed     Abstract available


  281. HOKAMA A, Omija H, Kishimoto K, Kinjo T, et al
    Response to "Histopathological Mimics of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892558. doi: 10.1093.
    PubMed    


  282. BATRA SK, Heier CR, Diaz-Calderon L, Tully CB, et al
    Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892560. doi: 10.1093.
    PubMed     Abstract available


  283. BERNSTEIN CN, Ng SC, Banerjee R, Steinwurz F, et al
    Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892568. doi: 10.1093.
    PubMed     Abstract available


  284. LIU C, Yuan ZY, Yuan H, Wu KX, et al
    Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892563. doi: 10.1093.
    PubMed     Abstract available


  285. LIN A, Roth H, Anyane-Yeboa A, Rubin DT, et al
    Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 Aug 11. pii: 5891018. doi: 10.1093.
    PubMed     Abstract available


  286. BORREN NZ, Plichta D, Joshi AD, Bonilla G, et al
    Multi-"-Omics" Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting Relapse.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885066. doi: 10.1093.
    PubMed     Abstract available


  287. LICHTENSTEIN GR, Rogler G, Ciorba MA, Su C, et al
    Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885008. doi: 10.1093.
    PubMed     Abstract available


  288. LO SASSO G, Khachatryan L, Kondylis A, Battey JND, et al
    Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885057. doi: 10.1093.
    PubMed     Abstract available


  289. GARRIDO I, Lopes S, Macedo G
    Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Aug 1. pii: 5879647. doi: 10.1093.
    PubMed    


    July 2020
  290. MAJSTER M, Lira-Junior R, Hoog CM, Almer S, et al
    Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2020 Jul 29. pii: 5877759. doi: 10.1093.
    PubMed     Abstract available


  291. JAGANNATH B, Lin KC, Pali M, Sankhala D, et al
    A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1beta and CRP as Potential Markers for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 28. pii: 5877396. doi: 10.1093.
    PubMed     Abstract available


  292. SEHGAL P, Ungaro RC, Foltz C, Iacoviello B, et al
    High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874745. doi: 10.1093.
    PubMed     Abstract available


  293. TIAN WN, Huang YH, Dai C
    The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874746. doi: 10.1093.
    PubMed    


  294. GREEN ME, Brahmbhatt B, Baumgarten D, Krishna M, et al
    Meckel's Diverticulum Masquerading as Crohn Disease.
    Inflamm Bowel Dis. 2020 Jul 21. pii: 5874417. doi: 10.1093.
    PubMed    


  295. VERDON C, Reinglas J, Coulombe J, Gonczi L, et al
    No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Quebec Provincial Database From 1996 to 2015.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872809. doi: 10.1093.
    PubMed     Abstract available


  296. NAVANEETHAN U, Lourdusamy D, LehnerNoguera V, Shen B, et al
    Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872834. doi: 10.1093.
    PubMed    


  297. CRISTOBAL I, Madoz-Gurpide J, Rojo F, Garcia-Foncillas J, et al
    The Molecular Mechanisms Involved in the miR-29a-5p/STAT3 Signaling Loop in Ulcerative Colitis-Associated Colorectal Cancer Still Remain Unclear.
    Inflamm Bowel Dis. 2020;26:e87.
    PubMed    


  298. BERINSTEIN JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, et al
    Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872817. doi: 10.1093.
    PubMed     Abstract available


  299. HERNANDEZ BENABE S, Langshaw AH
    IBD in the Times of COVID-19.
    Inflamm Bowel Dis. 2020;26:e92.
    PubMed    


  300. BAMIAS G, Lagou S, Gizis M, Karampekos G, et al
    The Greek Response to COVID-19: A True Success Story from an IBD Perspective.
    Inflamm Bowel Dis. 2020;26:1144-1148.
    PubMed     Abstract available


  301. GOYAL A
    Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
    Inflamm Bowel Dis. 2020;26:1222-1224.
    PubMed    


  302. AYOUB A, Jairath V, Aldraiweesh S, Khanna R, et al
    Safety of Biologic Therapy in Octogenarians and Nonagenarians With Inflammatory Bowel Disease in Ontario: A Case Series.
    Inflamm Bowel Dis. 2020 Jul 11. pii: 5870254. doi: 10.1093.
    PubMed    


  303. GEORGIOU AN, Ntritsos G, Papadimitriou N, Dimou N, et al
    Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867966. doi: 10.1093.
    PubMed     Abstract available


  304. DI RUSCIO M, Variola A, Angheben A, Resimini S, et al
    A Challenging Colectomy for Acute Severe Ulcerative Colitis Complicated by COVID-19.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867642. doi: 10.1093.
    PubMed    


  305. GROSSBERG LB, Pellish RS, Cheifetz AS, Feuerstein JD, et al
    Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866902. doi: 10.1093.
    PubMed    


  306. CARD TR, Zittan E, Nguyen GC, Grainge MJ, et al
    Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866856. doi: 10.1093.
    PubMed     Abstract available


  307. SAHU P, Kedia S, Padhan R, Ahuja V, et al
    Pregnancy-Onset Inflammatory Bowel Disease (PO-IBD): A Riddle Inside an Enigma.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866857. doi: 10.1093.
    PubMed    


    June 2020
  308. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    HPV-related Cancers in Inflammatory Bowel Disease: Association Not Yet Causation.
    Inflamm Bowel Dis. 2020 Jun 29. pii: 5864595. doi: 10.1093.
    PubMed    


  309. DULAI PS, Jairath V, Zou G, Stitt LW, et al
    Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863990. doi: 10.1093.
    PubMed     Abstract available


  310. PEPE M, Carulli E, Forleo C, Moscarelli M, et al
    Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863988. doi: 10.1093.
    PubMed     Abstract available


  311. LEE JA, Magavi PR, Konijeti GG
    Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863987. doi: 10.1093.
    PubMed    


  312. AXELRAD JE, Malter L, Hong S, Chang S, et al
    From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
    Inflamm Bowel Dis. 2020 Jun 24. pii: 5861860. doi: 10.1093.
    PubMed     Abstract available


  313. GRANT RK, Jones GR, Plevris N, Lynch RW, et al
    The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 23. pii: 5861142. doi: 10.1093.
    PubMed     Abstract available


  314. NAKASEKO H, Nishida D, Abe N, Tanaka K, et al
    Effect of Exclusive Enteral Nutrition on Renal Function for Granulomatous Interstitial Nephritis Associated With Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860630. doi: 10.1093.
    PubMed    


  315. HONAP S, Pavlidis P, Ray S, Sharma E, et al
    Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860628. doi: 10.1093.
    PubMed    


  316. SCHAFER E, Shyu I, Walker C, Smallfield G, et al
    New Presentation of Hepatic Inflammatory Pseudotumor and Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 20. pii: 5860196. doi: 10.1093.
    PubMed    


  317. KELSEN JR, Dawany N, Conrad MA, Karakasheva TA, et al
    Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes.
    Inflamm Bowel Dis. 2020 Jun 19. pii: 5859746. doi: 10.1093.
    PubMed     Abstract available


  318. TSURUTA Y, Furuta Y, Naoe H, Tanaka M, et al
    Multiple Gastric Polyps Improved After Treatment for Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 18. pii: 5859375. doi: 10.1093.
    PubMed    


  319. GUO L, Rohde J, Farraye FA
    Stigma and Disclosure in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:1010-1016.
    PubMed     Abstract available


  320. GRASSIA R, Soro S, Conti CB
    Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
    Inflamm Bowel Dis. 2020;26:e71.
    PubMed    


  321. FLESHNER P
    Editorial on Hirten et al.
    Inflamm Bowel Dis. 2020;26:1059.
    PubMed    


  322. LIGHTNER AL
    Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
    Inflamm Bowel Dis. 2020;26:1087-1088.
    PubMed    


  323. ORTEGA MORENO L, Fernandez-Tome S, Chaparro M, Marin AC, et al
    Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jun 17. pii: 5858322. doi: 10.1093.
    PubMed     Abstract available


  324. JEROME R, Sebastien H, Delphine WV, Jean-Francois E, et al
    Refractory Inflammatory Bowel Disease Associated With Sclerosing Cholangitis, Diabetes Insipidus, and Myeloid Neoplasm: Langerhans Cell Histiocytosis Was Hiding Since the Beginning.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856440. doi: 10.1093.
    PubMed    


  325. SCHLABITZ F, Teich N, Michl P, Walldorf J, et al
    Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856424. doi: 10.1093.
    PubMed    


  326. JOHN RA, Gearry RB
    Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient?
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856324. doi: 10.1093.
    PubMed    


  327. COELHO-PRABHU N, Bruining DH, Faubion WA, Kane SV, et al
    A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856329. doi: 10.1093.
    PubMed     Abstract available


  328. DUZENLI T, Koseoglu H, Akyol T
    NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854914. doi: 10.1093.
    PubMed    


  329. BERTANI L, Costa F, Barberio B, Savarino E, et al
    Reply to Letter to the Editor: NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854915. doi: 10.1093.
    PubMed    


  330. LIU B, Yang MQ, Yu TY, Yin YY, et al
    Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854445. doi: 10.1093.
    PubMed     Abstract available


  331. KOBAYASHI Y, Ohfuji S, Kondo K, Fukushima W, et al
    Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study in Japan.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854441. doi: 10.1093.
    PubMed     Abstract available


  332. QIAN XX
    Temporal, Sexual, and Geographic Distributions of the Coexistence of Ulcerative Colitis and Graves Disease.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854442. doi: 10.1093.
    PubMed    


  333. MARTIN ARRANZ E, Suarez Ferrer C, Garcia Ramirez L, Rueda Garcia JL, et al
    Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
    Inflamm Bowel Dis. 2020 Jun 4. pii: 5851307. doi: 10.1093.
    PubMed     Abstract available


  334. CHUDY-ONWUGAJE K, Mamunes AP, Schwartz DA, Horst S, et al
    Predictors of High Health Care Utilization in Patients With Inflammatory Bowel Disease Within 1 Year of Establishing Specialist Care.
    Inflamm Bowel Dis. 2020 Jun 3. pii: 5850604. doi: 10.1093.
    PubMed     Abstract available


  335. PEKOW J, Patel P
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Reply Letter to Elia et al.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850168. doi: 10.1093.
    PubMed    


  336. ELIA JR
    Aspirin, NSAIDs, and Inflammatory Bowel Disease: An Exercise Physiology Perspective.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850171. doi: 10.1093.
    PubMed    


    May 2020
  337. RAMPAL R, Wari N, Singh AK, Das U, et al
    Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNgamma Production.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848464. doi: 10.1093.
    PubMed     Abstract available


  338. NOURELDIN M, Cohen-Mekelburg S, Mahmood A, Stidham R, et al
    Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848467. doi: 10.1093.
    PubMed     Abstract available


  339. LEUNG KK, Tandon P, Govardhanam V, Maxwell C, et al
    The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848466. doi: 10.1093.
    PubMed     Abstract available


  340. MURPHY LK, de la Vega R, Kohut SA, Kawamura JS, et al
    Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 27. pii: 5847655. doi: 10.1093.
    PubMed     Abstract available


  341. VALDES DELGADO T, Maldonado Perez B, Castro Laria L
    Erythema Nodosum: As an Extraintestinal Manifestation or Complication in Ulcerative Colitis?
    Inflamm Bowel Dis. 2020 May 25. pii: 5843661. doi: 10.1093.
    PubMed     Abstract available


  342. KRONER PT, Lee A, Farraye FA
    Respiratory Tract Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843660. doi: 10.1093.
    PubMed     Abstract available


  343. QAZI T, Smith A, Alexander M, Hammer D, et al
    Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843655. doi: 10.1093.
    PubMed     Abstract available


  344. LYLES JL, Mulgund AA, Bauman LE, Su W, et al
    Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843647. doi: 10.1093.
    PubMed     Abstract available


  345. FASOULAS K, Kafalis N, Soufleris K
    Alphazathioprine-Induced Tremor: A Rare, Dose-Dependent Side Effect of Azathioprine in a Patient With Active Crohn Disease.
    Inflamm Bowel Dis. 2020 May 23. pii: 5843195. doi: 10.1093.
    PubMed    


  346. HUANG JS, Cruz R, Yueh R, Parker J, et al
    A Systemwide Electronic Health Record Checklist to Improve Comorbidity Screening of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841913. doi: 10.1093.
    PubMed    


  347. BARASH Y, Klang E, Tau N, Ben-Horin S, et al
    Evolution of Inflammatory Bowel Disease Research From a Bird's-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841908. doi: 10.1093.
    PubMed     Abstract available


  348. MARTINELLI M, Strisciuglio C, Fedele F, Miele E, et al
    Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841894. doi: 10.1093.
    PubMed    


  349. MINTZ MJ, Ananthakrishnan AN
    Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.
    Inflamm Bowel Dis. 2020 May 20. pii: 5840920. doi: 10.1093.
    PubMed     Abstract available


  350. DRAGONI G, De Hertogh G, Vermeire S
    The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?
    Inflamm Bowel Dis. 2020 May 19. pii: 5840491. doi: 10.1093.
    PubMed     Abstract available


  351. YU A, Friedman S, Ananthakrishnan AN
    Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840482. doi: 10.1093.
    PubMed     Abstract available


  352. EGBERG MD, Phillips M, Galanko JA, Kappelman M, et al
    Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840483. doi: 10.1093.
    PubMed     Abstract available


  353. RYBINSKI F, Weisser M, Niess JH, Hruz P, et al
    Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836916. doi: 10.1093.
    PubMed    


  354. BARNES EL, Bauer CM, Sandler RS, Kappelman MD, et al
    Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836912. doi: 10.1093.
    PubMed     Abstract available


  355. ROSEN MH, Axelrad J, Hudesman D, Rubin DT, et al
    Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
    Inflamm Bowel Dis. 2020 May 12. pii: 5836016. doi: 10.1093.
    PubMed     Abstract available


  356. XU F, Chen D, Yang Y
    Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e47.
    PubMed    


  357. MCHENRY S, Ciorba MA, Deepak P
    Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e46.
    PubMed    


  358. DAVIS BC
    Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Inflamm Bowel Dis. 2020;26:960.
    PubMed    


  359. ZUNDLER S
    Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
    Inflamm Bowel Dis. 2020;26:907-908.
    PubMed     Abstract available


  360. LUKIN DJ
    Predictors of Perianal Fistula Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:932-933.
    PubMed    


  361. KERUR B, Benchimol EI, Fiedler K, Stahl M, et al
    Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 May 9. pii: 5835042. doi: 10.1093.
    PubMed     Abstract available


  362. CORRIDONI D, Chapman T, Antanaviciute A, Satsangi J, et al
    Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834990. doi: 10.1093.
    PubMed     Abstract available


  363. GUZMAN-PRADO Y, Samson O, Segal JP, Limdi JK, et al
    Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834989. doi: 10.1093.
    PubMed     Abstract available


  364. TURSI A, Vetrone LM, Papa A
    Anti-TNF-alpha Agents in Inflammatory Bowel Disease and Course of COVID-19.
    Inflamm Bowel Dis. 2020 May 8. pii: 5831990. doi: 10.1093.
    PubMed    


  365. VAN GENNEP S, Evers SW, Rietdijk ST, Gielen ME, et al
    High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    Inflamm Bowel Dis. 2020 May 7. pii: 5831697. doi: 10.1093.
    PubMed     Abstract available


  366. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2020 May 6. pii: 5831199. doi: 10.1093.
    PubMed    


    April 2020
  367. JACOBS J, Clark-Snustad K, Lee S
    Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.
    Inflamm Bowel Dis. 2020 Apr 28. pii: 5826022. doi: 10.1093.
    PubMed    


  368. FENTON CG, Taman H, Florholmen J, Sorbye SW, et al
    Transcriptional Signatures That Define Ulcerative Colitis in Remission.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823961. doi: 10.1093.
    PubMed     Abstract available


  369. LEVHAR N, Ungar B, Kopylov U, Fudim E, et al
    Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823959. doi: 10.1093.
    PubMed     Abstract available


  370. YAO J, Jiang X, You JHS
    A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822887. doi: 10.1093.
    PubMed     Abstract available


  371. LINHARES M, Ramos D, Pereira F, Azevedo R, et al
    Hidradenitis Suppurativa and Crohn Disease: A Rare Association.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822088. doi: 10.1093.
    PubMed    


  372. DERER S, Brethack AK, Pietsch C, Jendrek ST, et al
    Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822108. doi: 10.1093.
    PubMed     Abstract available



  373. Corrigendum to: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822087. doi: 10.1093.
    PubMed    



  374. DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Apr 16. pii: 5820737. doi: 10.1093.
    PubMed    


  375. TURNER D
    Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
    Inflamm Bowel Dis. 2020;26:e42.
    PubMed    


  376. LIN S, Lin X, Li X, Chen M, et al
    Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
    Inflamm Bowel Dis. 2020;26:743-745.
    PubMed    


  377. LEE AS, Hubers J, Osman F, Caldera F, et al
    Don't Be Blue: A Case Series Describing Colonoscope Damage After Chromoendoscopy for Surveillance of Dysplasia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 6. pii: 5816423. doi: 10.1093.
    PubMed    


    March 2020
  378. BERTANI L, Rossari F, Barberio B, Demarzo MG, et al
    Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
    Inflamm Bowel Dis. 2020 Mar 31. pii: 5813970. doi: 10.1093.
    PubMed     Abstract available


  379. PATEL P, Gao G, Gulotta G, Dalal S, et al
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 27. pii: 5812729. doi: 10.1093.
    PubMed     Abstract available


  380. ORFANOUDAKI E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE, et al
    Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 24. pii: 5811190. doi: 10.1093.
    PubMed    


  381. MCCURDY JD, Benchimol EI
    Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Mar 21. pii: 5810826. doi: 10.1093.
    PubMed    


  382. XIE H, Zeng D, Chen D, Tang W, et al
    Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Mar 20. pii: 5810369. doi: 10.1093.
    PubMed    


  383. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 18. pii: 5809340. doi: 10.1093.
    PubMed     Abstract available


  384. OSTERMAN MT, Scott FI, Fogt FF, Gilroy ED, et al
    Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
    Inflamm Bowel Dis. 2020 Mar 14. pii: 5805376. doi: 10.1093.
    PubMed     Abstract available


  385. YVELLEZ OV, Rai V, Sossenheimer PH, Hart J, et al
    Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
    Inflamm Bowel Dis. 2020 Mar 10. pii: 5802337. doi: 10.1093.
    PubMed     Abstract available


  386. BODIWALA V, Marshall T, Das KM, Brant SR, et al
    Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799010. doi: 10.1093.
    PubMed     Abstract available


  387. KARMIRIS K
    Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners?
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799011. doi: 10.1093.
    PubMed    


  388. GEORGE LA, Cross RK
    How Do We Sequence Biologic Therapies in 2019?
    Inflamm Bowel Dis. 2020;26:617-618.
    PubMed    


  389. SYAL G, Melmed GY
    Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?
    Inflamm Bowel Dis. 2020;26:603-605.
    PubMed    


  390. ROSH JR
    The Cost of Pediatric IBD Care: How to Best Invest in our Children.
    Inflamm Bowel Dis. 2020;26:641-642.
    PubMed    


  391. LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
    Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
    Inflamm Bowel Dis. 2020;26:510-514.
    PubMed     Abstract available


  392. BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
    Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
    Inflamm Bowel Dis. 2020;26:628-634.
    PubMed     Abstract available


  393. JANGI S, Ruan A, Korzenik J, de Silva P, et al
    South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype.
    Inflamm Bowel Dis. 2020 Mar 2. pii: 5771121. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  394. LIN E, Katz S
    Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
    Inflamm Bowel Dis. 2020 Feb 26. pii: 5758182. doi: 10.1093.
    PubMed    


  395. DAI C, Cao Q, Jiang M
    Risk of Venous Thromboembolism After Hospital Discharge in Patients with Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2020 Feb 25. pii: 5755895. doi: 10.1093.
    PubMed    


  396. LI H, Tian F
    Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748143. doi: 10.1093.
    PubMed    


  397. LEY D, Martin B, Caldera F
    Use of an iPhone Application to Increase Adherence in Patients With Ulcerative Colitis in Remission: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748139. doi: 10.1093.
    PubMed    


  398. PEVERELLE M, Mills C, Testro A, Gow P, et al
    Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 20. pii: 5741005. doi: 10.1093.
    PubMed    


  399. OKAMOTO D, Kawai Y, Kakuta Y, Naito T, et al
    Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array.
    Inflamm Bowel Dis. 2020 Feb 19. pii: 5740361. doi: 10.1093.
    PubMed     Abstract available


  400. HAMDEH S, Aziz M, Altayar O, Olyaee M, et al
    Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 17. pii: 5739148. doi: 10.1093.
    PubMed     Abstract available


  401. LAW CCY, Koh D, Bao Y, Jairath V, et al
    Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 12. pii: 5734556. doi: 10.1093.
    PubMed     Abstract available


  402. PIGNICZKI D, Farkas K, Molnar T
    The Theoretical Scenario Experienced in a Real-Life Case of Ulcerative Colitis and Associated Primary Sclerosing Cholangitis: Case 123.
    Inflamm Bowel Dis. 2020 Feb 11. pii: 5733139. doi: 10.1093.
    PubMed    


  403. LEE TW
    Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression.
    Inflamm Bowel Dis. 2020;26:460-461.
    PubMed    


  404. BERNSTEIN CN
    Is Antibiotic Use a Cause of IBD Worldwide?
    Inflamm Bowel Dis. 2020;26:448-449.
    PubMed    


  405. GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
    Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
    Inflamm Bowel Dis. 2020;26:e17-e18.
    PubMed    


  406. JUKEMA JB, Brandse JF, de Boer NKH
    Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Inflamm Bowel Dis. 2020;26:e19.
    PubMed    


  407. SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
    The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Inflamm Bowel Dis. 2020;26:407-422.
    PubMed     Abstract available


  408. JUN X, Ning C, Yang S, Zhe W, et al
    Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Inflamm Bowel Dis. 2020;26:380-390.
    PubMed     Abstract available


  409. CORDES F, Lenker E, Spille LJ, Weinhage T, et al
    Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Inflamm Bowel Dis. 2020;26:391-406.
    PubMed     Abstract available


  410. VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
    The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
    Inflamm Bowel Dis. 2020;26:369-379.
    PubMed     Abstract available


  411. GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
    Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
    Inflamm Bowel Dis. 2020;26:423-428.
    PubMed     Abstract available


  412. EL-DALLAL M, Chen Y, Lin Q, Rakowsky S, et al
    Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
    Inflamm Bowel Dis. 2020 Feb 8. pii: 5731339. doi: 10.1093.
    PubMed     Abstract available


  413. KORNBLUTH A
    Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Inflamm Bowel Dis. 2020 Feb 7. pii: 5729887. doi: 10.1093.
    PubMed    


  414. CARNEY H, Marrie RA, Bolton JM, Patten SB, et al
    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 6. pii: 5728525. doi: 10.1093.
    PubMed     Abstract available


  415. PENG Y, Thomas AS, Wei D, Tan D, et al
    An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
    Inflamm Bowel Dis. 2020 Feb 4. pii: 5721970. doi: 10.1093.
    PubMed    


  416. JABANDZIEV P, Bohosova J, Pinkasova T, Kunovsky L, et al
    The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 3. pii: 5721205. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  417. MCCURDY JD, Kuenzig ME, Smith G, Spruin S, et al
    Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717328. doi: 10.1093.
    PubMed     Abstract available


  418. BAFFORD AC, Cross RK
    Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond Hospitalization.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717307. doi: 10.1093.
    PubMed    


  419. SZANTO KJ, Rutka M, Pigniczki D, Farkas K, et al
    Serological Status of Inflammatory Bowel Disease Patients Before Starting Biological Therapy - Data From a Tertiary Centre of the Best Vaccined Country.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715025. doi: 10.1093.
    PubMed    


  420. MARTINELLI M, Miele E
    Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715024. doi: 10.1093.
    PubMed    


  421. LEE AA, Rao K, Limsrivilai J, Gillilland M, et al
    Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 23. pii: 5714595. doi: 10.1093.
    PubMed     Abstract available


  422. COLLINS SM
    Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714219. doi: 10.1093.
    PubMed     Abstract available


  423. HOU G, Bishu S
    Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714220. doi: 10.1093.
    PubMed    


  424. CONRAD MA, Kelsen JR
    Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714218. doi: 10.1093.
    PubMed    


  425. GUPTA N, Liu C, King E, Sylvester F, et al
    Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714217. doi: 10.1093.
    PubMed     Abstract available


  426. PRATHAPAN KM, Ramos Rivers C, Anderson A, Koutroumpakis F, et al
    Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 21. pii: 5711281. doi: 10.1093.
    PubMed     Abstract available


  427. GUBATAN J, Mehigan GA, Villegas F, Mitsuhashi S, et al
    Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2020 Jan 18. pii: 5709590. doi: 10.1093.
    PubMed     Abstract available


  428. DIN H, Anderson AJ, Ramos Rivers C, Proksell S, et al
    Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707489. doi: 10.1093.
    PubMed     Abstract available


  429. MARTINELLI M, Miele E
    Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707490. doi: 10.1093.
    PubMed    


  430. EL-MATARY W
    Routine Testing for EBV Status in Children With Inflammatory Bowel Disease: Are We Overreacting?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707482. doi: 10.1093.
    PubMed    


  431. KATINIOS G, Casado-Bedmar M, Walter SA, Vicario M, et al
    Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707481. doi: 10.1093.
    PubMed     Abstract available


  432. PEVERELLE M, Paleri S, Hughes J, De Cruz P, et al
    Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707461. doi: 10.1093.
    PubMed     Abstract available


  433. WONG U, Cross RK
    Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707487. doi: 10.1093.
    PubMed    


  434. PERRY C, Kapur N, Barrett TA
    DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698302. doi: 10.1093.
    PubMed    


  435. PINTO-LOPES P, Afonso J, Pinto-Lopes R, Rocha C, et al
    Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698249. doi: 10.1093.
    PubMed     Abstract available


  436. ROOSENBOOM B, van Lochem EG, Smids C, Groenen MJM, et al
    Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:e13.
    PubMed    


  437. BAUER CM, Younis A, Herfarth H, Barnes EL, et al
    Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e5.
    PubMed    


  438. CASANOVA MJ, Chaparro M, Gisbert JP
    Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e6.
    PubMed    


  439. BARNES EL
    Opportunistic Infections and Opportunities for Action.
    Inflamm Bowel Dis. 2020;26:301-303.
    PubMed    


  440. ANNESE V
    TDM of Anti-TNF Agents: The Importance of Being Active!
    Inflamm Bowel Dis. 2020;26:271-272.
    PubMed    


  441. CHANG S, Hamilton M, Lees C, Atreja A, et al
    Mobile Health in IBD: Enhancing Care, One Phone at a Time.
    Inflamm Bowel Dis. 2020;26:163-166.
    PubMed    


  442. WANDERS LK, Cordes M, Voorham Q, Sie D, et al
    IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Inflamm Bowel Dis. 2020;26:167-180.
    PubMed     Abstract available


  443. KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
    Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Inflamm Bowel Dis. 2020;26:216-228.
    PubMed     Abstract available


  444. WANG X, Bootsma H, Kroese F, Dijkstra G, et al
    Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
    Inflamm Bowel Dis. 2020;26:e8-e9.
    PubMed    


  445. LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
    Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:304-313.
    PubMed     Abstract available


  446. EGBERG MD, Galanko JA, Kappelman MD
    Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
    Inflamm Bowel Dis. 2020;26:254-260.
    PubMed     Abstract available


  447. LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
    Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Inflamm Bowel Dis. 2020;26:321-330.
    PubMed     Abstract available


  448. MORAES L, Magnusson MK, Mavroudis G, Polster A, et al
    Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Inflamm Bowel Dis. 2020 Jan 4. pii: 5696669. doi: 10.1093.
    PubMed     Abstract available


  449. YU A, Friedman S, Ananthakrishnan AN
    Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 2. pii: 5694104. doi: 10.1093.
    PubMed     Abstract available


  450. KUROWSKI JA, Achkar JP
    Underutilization of Combination Anti-TNF Therapy in Population-based Study.
    Inflamm Bowel Dis. 2020;26:158-159.
    PubMed    


  451. DE FELICE KM
    Patients Perception of Risks and Benefits of Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:147-149.
    PubMed     Abstract available


  452. FRANCO DL, Click B
    Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?
    Inflamm Bowel Dis. 2020;26:112-113.
    PubMed    


  453. SILVA JC, Rodrigues A, Carvalho J
    Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn's Disease: Challenges in Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:e1-e2.
    PubMed    


  454. CHIBA M, Tsuji T, Nakane K, Obara Y, et al
    Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e4.
    PubMed    


  455. SHANKAR U, Vijayasekar K, Bansal R, Walfish A, et al
    Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission.
    Inflamm Bowel Dis. 2020;26:e3.
    PubMed    


  456. FAHAD H, Abu-Elmagd K, Lashner B, Fiocchi C, et al
    Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction.
    Inflamm Bowel Dis. 2020;26:21-23.
    PubMed     Abstract available


  457. YU Y, Yang W, Li Y, Cong Y, et al
    Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2020;26:11-20.
    PubMed     Abstract available


  458. WILSON R, Gundamaraju R, Vemuri R, Angelucci C, et al
    Identification of Key Pro-Survival Proteins in Isolated Colonic Goblet Cells of Winnie, a Murine Model of Spontaneous Colitis.
    Inflamm Bowel Dis. 2020;26:80-92.
    PubMed     Abstract available


  459. ELIAS ED, Targownik LE, Singh H, Bernstein CN, et al
    A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD.
    Inflamm Bowel Dis. 2020;26:150-157.
    PubMed     Abstract available


  460. KOLIANI-PACE JL, Haron AM, Zisman-Ilani Y, Thompson KD, et al
    Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications.
    Inflamm Bowel Dis. 2020;26:141-146.
    PubMed     Abstract available


  461. STOLZER I, Kaden-Volynets V, Ruder B, Letizia M, et al
    Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation.
    Inflamm Bowel Dis. 2020;26:66-79.
    PubMed     Abstract available


  462. CHRISTIAN KE, Russman KM, Rajan DP, Barr EA, et al
    Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical Trials.
    Inflamm Bowel Dis. 2020;26:125-131.
    PubMed     Abstract available


  463. WINTER RW, Friedman S
    Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications.
    Inflamm Bowel Dis. 2020;26:132-133.
    PubMed    


  464. NEGOESCU DM, Enns EA, Swanhorst B, Baumgartner B, et al
    Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.
    Inflamm Bowel Dis. 2020;26:103-111.
    PubMed     Abstract available


  465. PASHA SF, Pennazio M, Rondonotti E, Wolf D, et al
    Capsule Retention in Crohn's Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2020;26:33-42.
    PubMed     Abstract available


    December 2019
  466. DAI C, Jiang M, Sun MJ
    Disease Duration and the Risk of Treatment Failure in Biologic-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 30. pii: 5690100. doi: 10.1093.
    PubMed    


  467. KEVANS D, Kirsch R, Dargavel C, Kabakchiev B, et al
    Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688912. doi: 10.1093.
    PubMed     Abstract available


  468. ESCUDERO-HERNANDEZ C, Montalvillo E, Antolin B, Bernardo D, et al
    Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688873. doi: 10.1093.
    PubMed    


  469. FAYE AS, Oh A, Kumble LD, Kiran RP, et al
    Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Dec 27. pii: 5688242. doi: 10.1093.
    PubMed     Abstract available


  470. KUENZIG ME, Hawken S, Wilson K, Talarico R, et al
    Serum Newborn Screening Blood Metabolites Are not Associated With Childhood-onset Inflammatory Bowel Disease: A Population-based Matched Case-control Study.
    Inflamm Bowel Dis. 2019 Dec 12. pii: 5674034. doi: 10.1093.
    PubMed     Abstract available


  471. CHEN LA
    Intestinal Microbiota Transplantation for Patients With Inflammatory Bowel Disease Prevents Recurrence of C. difficile Infections but Not Recurrence of Gastrointestinal Symptoms.
    Inflamm Bowel Dis. 2019 Dec 10. pii: 5673070. doi: 10.1093.
    PubMed    


  472. TARIQ R, Disbrow MB, Dibaise JK, Orenstein R, et al
    Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 9. pii: 5673067. doi: 10.1093.
    PubMed     Abstract available


  473. POUILLON L, Hoefkens E, Verheyen V, Bronswijk M, et al
    Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650900. doi: 10.1093.
    PubMed    


  474. YANG B, Liu X, Mei Q
    HMGB1-Positive Platelet Microparticles May Be a Biomarker of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650909. doi: 10.1093.
    PubMed    



  475. Corrigendum to A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650796. doi: 10.1093.
    PubMed    


  476. OUAHED J, Spencer E, Kotlarz D, Shouval DS, et al
    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5675340. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  477. CHENG J, Shen H, Chowdhury R, Abdi T, et al
    Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648005. doi: 10.1093.
    PubMed     Abstract available


  478. JODELEIT H, Caesar J, Villarroel Aguilera C, Sterz S, et al
    The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rgamma null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648003. doi: 10.1093.
    PubMed     Abstract available


  479. CHATEAU T, Peyrin-Biroulet L
    Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.
    Inflamm Bowel Dis. 2019 Nov 26. pii: 5643743. doi: 10.1093.
    PubMed    


  480. CHANDRAKUMAR A, Zohni H, El-Matary W
    Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 25. pii: 5643019. doi: 10.1093.
    PubMed     Abstract available


  481. BASSON AR, Gomez-Nguyen A, Menghini P, Butto LF, et al
    Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5637456. doi: 10.1093.
    PubMed     Abstract available


  482. NGUYEN NH, Kurnool S, Dulai PS, Boland BS, et al
    Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5636894. doi: 10.1093.
    PubMed     Abstract available


  483. MARCIL V, Levy E, Amre D, Bitton A, et al
    Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Nov 20. pii: 5634260. doi: 10.1093.
    PubMed    


  484. THAKUR ER, Sansgiry S, Kramer JR, Waljee AK, et al
    The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 15. pii: 5625871. doi: 10.1093.
    PubMed     Abstract available


  485. HANSEN TM, Sabourin BC, Oketola B, Bernstein CN, et al
    Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Inflamm Bowel Dis. 2019 Nov 14. pii: 5625670. doi: 10.1093.
    PubMed     Abstract available


  486. SHMIDT E, Saha S, Sands BE
    Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Inflamm Bowel Dis. 2019;25:e166.
    PubMed    


  487. FAYE AS, Hung KW, Cheng K, Blackett JW, et al
    Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613524. doi: 10.1093.
    PubMed     Abstract available


  488. MARTINELLI M, Giugliano FP, Strisciuglio C, Urbonas V, et al
    Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613525. doi: 10.1093.
    PubMed     Abstract available


  489. LOPETUSO LR, Gasbarrini A
    Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613523. doi: 10.1093.
    PubMed    


  490. VADSTRUP K, Alulis S, Borsi A, Gustafsson N, et al
    Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Inflamm Bowel Dis. 2019 Nov 4. pii: 5613986. doi: 10.1093.
    PubMed     Abstract available


  491. DE JONG ME, Gillis VELM, Derikx LAAP, Hoentjen F, et al
    No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps.
    Inflamm Bowel Dis. 2019 Nov 2. pii: 5611176. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  492. SHAH NB, Haydek J, Slaughter J, Ashton JR, et al
    Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610710. doi: 10.1093.
    PubMed     Abstract available


  493. CLICK B, Lopez R, Arrigain S, Schold J, et al
    Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610752. doi: 10.1093.
    PubMed     Abstract available


  494. TRUTA B, Leeds IL, Canner JK, Efron JE, et al
    Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610578. doi: 10.1093.
    PubMed     Abstract available


  495. GU P, Feagins LA
    Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610412. doi: 10.1093.
    PubMed     Abstract available


  496. AL DRAIWEESH S, Ma C, Alkhattabi M, McDonald C, et al
    Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 28. pii: 5608313. doi: 10.1093.
    PubMed     Abstract available


  497. MCCOMBIE A, Walmsley R, Barclay M, Ho C, et al
    A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 23. pii: 5603780. doi: 10.1093.
    PubMed     Abstract available


  498. CALVET X, Saldana R, Carpio D, Minguez M, et al
    Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5571234. doi: 10.1093.
    PubMed     Abstract available


  499. BARNES EL, Jiang Y, Kappelman MD, Long MD, et al
    Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601649. doi: 10.1093.
    PubMed     Abstract available


  500. HAAC BE, Nemirovsky A, Teeter W, Geyer A, et al
    Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601417. doi: 10.1093.
    PubMed     Abstract available


  501. GROSSI V, Hyams JS, Glidden NC, Knight BE, et al
    Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5599699. doi: 10.1093.
    PubMed     Abstract available


  502. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    Erratum: The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2019;25:e152.
    PubMed    


  503. WANG MH, Mousa OY, Friton JJ, Raffals LE, et al
    Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5593848. doi: 10.1093.
    PubMed     Abstract available


  504. VAN DER HAVE M, Oldenburg B
    Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598454. doi: 10.1093.
    PubMed    


  505. SINGH A, Koenen B, Kirby DF
    Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598917. doi: 10.1093.
    PubMed     Abstract available


  506. KANE S
    Contraception and Antibiotics.
    Inflamm Bowel Dis. 2019;25:e148.
    PubMed    


  507. MIRJALALI H, Shahrokh S, Asadzadeh Aghdaei H, Zali MR, et al
    Letter to the Editor: Activated Toxoplasma May Attenuate the Effect of Azathioprine and Deteriorate the Symptoms in IBD Patients via mTORC1 Manipulation.
    Inflamm Bowel Dis. 2019;25:e137.
    PubMed    


  508. EISENSTEIN S, Holubar SD, Hilbert N, Bordeianou L, et al
    The ACS National Surgical Quality Improvement Program-Inflammatory Bowel Disease Collaborative: Design, Implementation, and Validation of a Disease-specific Module.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589173. doi: 10.1093.
    PubMed     Abstract available


  509. LAI SW, Kuo YH, Fang CW, Liao KF, et al
    Inflammatory Bowel Disease and the Risk of Erectile Dysfunction.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589171. doi: 10.1093.
    PubMed    


  510. WATT P
    Recommendations for the Provision of Psychological Support in a Rural Inflammatory Bowel Disease Clinic.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589169. doi: 10.1093.
    PubMed    


  511. NETO MBB, Gregory MH, Ramos GP, Bazerbachi F, et al
    Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588067. doi: 10.1093.
    PubMed     Abstract available


  512. KAFIL TS, Nguyen TM, MacDonald JK, Chande N, et al
    Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588062. doi: 10.1093.
    PubMed     Abstract available


  513. LAI SW, Kuo YH, Liao KF
    Cancer Risk in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 14. pii: 5587055. doi: 10.1093.
    PubMed    


  514. SCHOFIELD JB, Haboubi N
    Histopathological Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 10. pii: 5584939. doi: 10.1093.
    PubMed     Abstract available


  515. KRISHNA M, Salako A, Fofanova T, Kellermayer R, et al
    Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581966. doi: 10.1093.
    PubMed     Abstract available


  516. DAY AS
    Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581964. doi: 10.1093.
    PubMed    


  517. NARDONE OM, Shivaji UN, Ferruzza V, Ghosh S, et al
    Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581902. doi: 10.1093.
    PubMed     Abstract available


  518. KAYAL M, Plietz M, Rizvi A, Radcliffe M, et al
    Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581903. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  519. DANILUK U, Daniluk J, Ciborowski M
    Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574842. doi: 10.1093.
    PubMed    


  520. SITKIN S, Demyanova E, Vakhitov T, Pokrotnieks J, et al
    Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574840. doi: 10.1093.
    PubMed    


  521. CHANDE N, Costello SP, Limketkai BN, Parker CE, et al
    Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574841. doi: 10.1093.
    PubMed    


  522. MOSER T, Bubel NE, Machegger L, Pikija S, et al
    Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition?
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574838. doi: 10.1093.
    PubMed    


  523. KELSEN JR, Conrad MA, Dawany N, Patel T, et al
    The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5575070. doi: 10.1093.
    PubMed     Abstract available


  524. GIRON F, Pasto A, Tasciotti E, Abraham BP, et al
    Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574918. doi: 10.1093.
    PubMed     Abstract available


  525. LONG MD, Smith TW, Dibonaventura M, Gruben D, et al
    Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574848. doi: 10.1093.
    PubMed     Abstract available


  526. ABU-SBEIH H, Wang Y
    Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574910. doi: 10.1093.
    PubMed     Abstract available


  527. NGUYEN GC, Low D, Chong RY, Diong C, et al
    Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574895. doi: 10.1093.
    PubMed     Abstract available


  528. CHIBA M, Nakane K, Abe H, Komatsu M, et al
    Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574851. doi: 10.1093.
    PubMed     Abstract available


  529. CLARKE WT, Papamichael K, Casteele NV, Germansky KA, et al
    Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574728. doi: 10.1093.
    PubMed    


  530. VAN DE VEN SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, et al
    Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574717. doi: 10.1093.
    PubMed     Abstract available


  531. BOLAND K, Greener T, Kabakchiev B, Stempak J, et al
    Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
    Inflamm Bowel Dis. 2019 Sep 17. pii: 5570706. doi: 10.1093.
    PubMed     Abstract available


  532. LUTHER J, Dave M
    Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.
    Inflamm Bowel Dis. 2019 Sep 7. pii: 5565004. doi: 10.1093.
    PubMed    


    August 2019
  533. DEBRUYN J
    Response to the Letter by Dr. Freddy Calder.
    Inflamm Bowel Dis. 2019;25:e104.
    PubMed    


    July 2019
  534. BORUM ML, Taneja SL, Corinaldi M
    Health Literacy Assessments May Be Inconsistently Conducted in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e94.
    PubMed    


  535. SAROLI PALUMBO C, Bessissow T, Sebastiani G
    Reply to "Transient Elastography in IBD Patients".
    Inflamm Bowel Dis. 2019;25:e95.
    PubMed    


  536. VAN EVERDINGEN CK, Meijer B, Gearry RB
    Transient Elastography in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e96.
    PubMed    


  537. GOYAL A, Morowitz M
    Author's Reply to Drs. Franco Scaldaferri and Valentina Petito, PhD.
    Inflamm Bowel Dis. 2019;25:e102.
    PubMed    


  538. KOCHAR B, Long MD, Herfarth HH
    Antidepressants in IBD: Healthy Adherer Effect?
    Inflamm Bowel Dis. 2019;25:e98.
    PubMed    


  539. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Response to Letter by Moulton et al.
    Inflamm Bowel Dis. 2019;25:e99.
    PubMed    


    June 2019
  540. ZHAO S, Xie Q, Zhao Z
    Reply to Comment on "Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis" by Li Y and Liu X.
    Inflamm Bowel Dis. 2019;25:e78-e81.
    PubMed    


  541. GIANNINI EG, Demarzo MG, Bodini G
    Reproducibility and Transportability of the Absence of Incremental Infectious Adverse Events in Patients With Higher Anti-TNF Drug Levels.
    Inflamm Bowel Dis. 2019;25:e73.
    PubMed    


  542. KRUGER AJ, Hinton A, Afzali A
    To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2019;25:e74-e76.
    PubMed    


  543. KURIN M, Katz J, Kodish E, Lashner B, et al
    Informed Consent in IBD Trials: Where We Are and Where We Need to Go.
    Inflamm Bowel Dis. 2019;25:1115-1119.
    PubMed     Abstract available


  544. GROSSBERG LB
    A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab.
    Inflamm Bowel Dis. 2019;25:e84.
    PubMed    


  545. GARCIA GARCIA MJ, Rivero Tirado M, Callizo MEP
    Paradoxical Arthritis in Inflammatory Bowel Diasease Patients on Ustekinumab Treatment.
    Inflamm Bowel Dis. 2019;25:e89.
    PubMed    


  546. SIMONS-LINARES CR, Chahal P
    Successful EUS-guided Drainage of a Persistent Subdiaphragmatic Fluid Collection in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e85-e86.
    PubMed    


  547. LIGHTNER AL, Alsughayer A, Wang Z, McKenna NP, et al
    Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic Review.
    Inflamm Bowel Dis. 2019;25:1152-1168.
    PubMed     Abstract available


  548. KRISHNAKUMAR C, Ballengee CR, Liu C, Kim MO, et al
    Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Inflamm Bowel Dis. 2019;25:1208-1217.
    PubMed     Abstract available


  549. ZHAO M, Lo BZS, Vester-Andersen MK, Vind I, et al
    A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.
    Inflamm Bowel Dis. 2019;25:1227-1236.
    PubMed     Abstract available


  550. EVERHOV AH, Khalili H, Askling J, Myrelid P, et al
    Work Loss Before and After Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1237-1247.
    PubMed     Abstract available


    May 2019
  551. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Reply to the Letter to the Editor of Drs. Sitkin and Pokrotnieks.
    Inflamm Bowel Dis. 2019;25:e72.
    PubMed    


  552. FUKUDA T, Naganuma M, Kanai T
    How Can We Assess "Complete Healing" Beyond Endoscopic Remission?
    Inflamm Bowel Dis. 2019;25:e68.
    PubMed    


  553. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e62-e63.
    PubMed    


  554. DAI C, Jiang M, Huang YH
    The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e61.
    PubMed    


  555. GREENFEST A, Szvarca D, Clarke L, Tabbara N, et al
    New Vaccine, New Guidelines, Same Problem: The Rates of Herpes Zoster Infection and Vaccination in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e60.
    PubMed    


  556. COUCH DG, Cook H, Ortori C, Barrett D, et al
    Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Inflamm Bowel Dis. 2019;25:1006-1018.
    PubMed     Abstract available


  557. CALDERA F, Hayney MS, Cross RK
    Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
    Inflamm Bowel Dis. 2019;25:955-957.
    PubMed    


  558. MOORE AC, Huang VW, Bourdages R, Fedorak RN, et al
    IBDoc Canadian User Performance Evaluation.
    Inflamm Bowel Dis. 2019;25:1107-1114.
    PubMed     Abstract available


  559. KOTZEV A, Tanchev L, Encheva L, Kovachev N, et al
    Sigmoidouterine Fistula in Crohn's Disease: A First Case Report.
    Inflamm Bowel Dis. 2019;25:e65-e66.
    PubMed    


  560. QAZI T, Verma R, Hamilton MJ, Kaplan ER, et al
    The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1044-1053.
    PubMed     Abstract available


  561. SADO AI, Kalla R, Sharma A
    A Case of IBD Immunosuppression Related Salmonella Aortitis Requiring Emergency Vascular Grafting.
    Inflamm Bowel Dis. 2019;25:e64.
    PubMed    


  562. SCHMIDT T, Feagins LA
    How Can We Improve to Keep Our Patients Out of the Hospital?
    Inflamm Bowel Dis. 2019;25:980-986.
    PubMed     Abstract available


  563. PARK SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al
    Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Inflamm Bowel Dis. 2019;25:1054-1060.
    PubMed     Abstract available


  564. PLEVRIS N, Lyons M, Jenkinson PW, Chuah CS, et al
    Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
    Inflamm Bowel Dis. 2019;25:1036-1043.
    PubMed     Abstract available


    April 2019
  565. SHMIDT E, Dulai PS
    Reply to the Letter to the Editor of Dr. Pauwels et al.
    Inflamm Bowel Dis. 2019;25:e58.
    PubMed    


  566. JUN S
    Ethnicity May Be Important for Studying the Role of the Microbiome and Vitamin D Receptor in IBD.
    Inflamm Bowel Dis. 2019;25:e54.
    PubMed    


  567. SZYMCZAK-TOMCZAK A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, et al
    Does Only Sex Matter? Complexity of the Association Between Vdr Gene BsmI Single Nucleotide Polymorphism and Immune Response in IBD.
    Inflamm Bowel Dis. 2019;25:e56-e57.
    PubMed    


  568. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sanders DS, et al
    Small Bowel Ulcers on Capsule Endoscopy and Their Significance.
    Inflamm Bowel Dis. 2019;25:e55.
    PubMed    


  569. KANE S
    Leter to the Editor.
    Inflamm Bowel Dis. 2019;25:e52.
    PubMed    


  570. FRANCO DL, Holubar SD, Lightner AL, Lashner BA, et al
    Local Stem Cell Therapy for Crohn's Perianal Fistulae.
    Inflamm Bowel Dis. 2019;25:816-819.
    PubMed    


  571. SCOTT FI, Johnson FR, Bewtra M, Brensinger CM, et al
    Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:925-936.
    PubMed     Abstract available


  572. CHUDY-ONWUGAJE KO, Christian KE, Farraye FA, Cross RK, et al
    A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.
    Inflamm Bowel Dis. 2019;25:820-830.
    PubMed     Abstract available


  573. CLICK B, Regueiro M
    A Practical Guide to the Safety and Monitoring of New IBD Therapies.
    Inflamm Bowel Dis. 2019;25:831-842.
    PubMed     Abstract available


  574. NUCERA E, Andriollo G, Buonomo A, Di Rienzo A, et al
    Interesting Case of Infliximab IV Type Hypersensitivity.
    Inflamm Bowel Dis. 2019;25:e49-e51.
    PubMed    


    March 2019
  575. GOREN I, Godny L, Reshef L, Yanai H, et al
    Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
    Inflamm Bowel Dis. 2019;25:742-749.
    PubMed     Abstract available


  576. ZHAO S, Wang J, Liu Y, Luo L, et al
    Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis.
    Inflamm Bowel Dis. 2019;25:699-707.
    PubMed     Abstract available


  577. WEAVER KN, Gregory M, Syal G, Hoversten P, et al
    Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
    Inflamm Bowel Dis. 2019;25:767-774.
    PubMed     Abstract available


  578. DURICOVA D, Dvorakova E, Hradsky O, Mitrova K, et al
    Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
    Inflamm Bowel Dis. 2019;25:789-796.
    PubMed     Abstract available


  579. CARUSO ML, Cavalcanti E, Ignazzi A, Lantone G, et al
    Infliximab Has a Number of Well-Described Adverse Effects. Is Myeloid Metaplasia One of These in Elderly Long-standing IBD Patients?
    Inflamm Bowel Dis. 2019;25:e44-e45.
    PubMed    


    February 2019
  580. MAO R, Kurada S, Gordon IO, Baker ME, et al
    The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:421-426.
    PubMed     Abstract available


  581. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:592-600.
    PubMed     Abstract available


  582. ARMUZZI A, Fiorino G, Variola A, Manetti N, et al
    The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.
    Inflamm Bowel Dis. 2019;25:568-579.
    PubMed     Abstract available


  583. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:547-560.
    PubMed     Abstract available


  584. QUINN KP, Lightner AL, Faubion WA, Raffals LE, et al
    A Comprehensive Approach to Pouch Disorders.
    Inflamm Bowel Dis. 2019;25:460-471.
    PubMed     Abstract available


  585. NUGENT Z, Singh H, Targownik LE, Bernstein CN, et al
    Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
    Inflamm Bowel Dis. 2019;25:532-540.
    PubMed     Abstract available


  586. MIZUNO S, Naganuma M, Kanai T
    Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e26.
    PubMed    


  587. NOVELLO M, Shen B, Stocchi L
    Pouchitis as an Indication for Ileal Pouch Surgical Revision.
    Inflamm Bowel Dis. 2019;25:e25.
    PubMed    


  588. GLAPA A, Waraczewski K, Nowak JK, Paszkowski J, et al
    Vitamin K Deficiency in Patients After Restorative Proctocolectomy.
    Inflamm Bowel Dis. 2019;25:e17-e18.
    PubMed    


  589. EL OUALI S, Kessler H, Shen B
    Self-Expandable Metal Stent in the Treatment of Refractory Long Pouch Inlet Stricture.
    Inflamm Bowel Dis. 2019;25:e13-e14.
    PubMed    


    January 2019
  590. DOVROLIS N, Drygiannakis I, Filidou E, Kandilogiannakis L, et al
    Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Inflamm Bowel Dis. 2019;25:217-225.
    PubMed     Abstract available


  591. WEIZMAN AV, Nguyen GC, Seow CH, Targownik L, et al
    Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.
    Inflamm Bowel Dis. 2019;25:328-335.
    PubMed     Abstract available


  592. SHEN W, Li Y, Zou Y, Cao L, et al
    Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System.
    Inflamm Bowel Dis. 2019;25:283-293.
    PubMed     Abstract available


  593. SCHIRBEL A, Rebert N, Sadler T, West G, et al
    Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.
    Inflamm Bowel Dis. 2019;25:294-305.
    PubMed     Abstract available


  594. BEN-SHACHAR S, Finezilber Y, Elad H, Rabinowitz K, et al
    Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:336-344.
    PubMed     Abstract available


  595. BITTON A, Vutcovici M, Lytvyak E, Kachan N, et al
    Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.
    Inflamm Bowel Dis. 2019;25:403-409.
    PubMed     Abstract available


  596. DURICOVA D, Sarter H, Savoye G, Leroyer A, et al
    Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Inflamm Bowel Dis. 2019;25:394-402.
    PubMed     Abstract available


  597. XU Y, Yang L, An P, Zhou B, et al
    Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:261-269.
    PubMed     Abstract available


  598. DEEPAK P, Fowler KJ, Fletcher JG, Bruining DH, et al
    Novel Imaging Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:248-260.
    PubMed     Abstract available


  599. SHAFER LA, Walker JR, Restall G, Chhibba T, et al
    Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Inflamm Bowel Dis. 2019;25:352-359.
    PubMed     Abstract available


  600. RIVERA ED, Coffey JC, Walsh D, Ehrenpreis ED, et al
    The Mesentery, Systemic Inflammation, and Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:226-234.
    PubMed     Abstract available


  601. RENOUF MJ, Cho YH, McPhee JB
    Emergent Behavior of IBD-Associated Escherichia coli During Disease.
    Inflamm Bowel Dis. 2019;25:33-44.
    PubMed     Abstract available


  602. BUTTO LF, Jia LG, Arseneau KO, Tamagawa H, et al
    Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:14-26.
    PubMed     Abstract available


  603. ZHANG YG, Lu R, Xia Y, Zhou D, et al
    Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Inflamm Bowel Dis. 2019;25:97-110.
    PubMed     Abstract available


  604. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:85-96.
    PubMed     Abstract available


  605. STEINHART AH, Panaccione R, Targownik L, Bressler B, et al
    Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
    Inflamm Bowel Dis. 2019;25:1-13.
    PubMed     Abstract available


  606. CUSHING KC, Mclean R, McDonald KG, Gustafsson JK, et al
    Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery.
    Inflamm Bowel Dis. 2019;25:180-193.
    PubMed     Abstract available


  607. SPENCER E, Norris E, Williams C, Dubinsky MC, et al
    The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Inflamm Bowel Dis. 2019;25:142-149.
    PubMed     Abstract available


  608. EL-MATARY W, Walters TD, Huynh HQ, deBruyn J, et al
    Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    Inflamm Bowel Dis. 2019;25:150-155.
    PubMed     Abstract available


  609. SAROLI PALUMBO C, Restellini S, Chao CY, Aruljothy A, et al
    Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
    Inflamm Bowel Dis. 2019;25:124-133.
    PubMed     Abstract available


  610. LEGA S, Phan BL, Rosenthal CJ, Gordon J, et al
    Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD.
    Inflamm Bowel Dis. 2019;25:134-141.
    PubMed     Abstract available


  611. DOTSON JL, Kappelman MD, Bricker J, Andridge R, et al
    Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status.
    Inflamm Bowel Dis. 2019;25:194-203.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: